Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A RAndomized trIal Examining the Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy for Patients With Stage 4-5 CKD or Dialysis-dependent ESKD

NCT04741074 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.

NCT NCT04741074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A RAndomized trIal Examining the Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy for Patients With Stage 4-5 CKD or Dialysis-dependent ESKD
Lead sponsor
Geisinger Clinic
Phase
Phase 3
Overall status
Terminated
Start date
July 23, 2021
Completion date
January 31, 2023
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, diabetic kidney disease, obesity, severe obesity, type 2 diabetes mellitus in obese